← Leaderboards
Paul Yager
University Of Washington
$14,080,210
Attributed
$14,285,452
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$14,285,452 · 8
By mechanism
R01$6,279,063 · 3
U01$3,827,585 · 1
R33$1,459,110 · 1
R61$1,318,776 · 1
RC1$990,434 · 1
R21$410,484 · 1
Top collaborators
- David Baker2 shared
Most similar at University Of Washington
Same institution · by research overlap
- David Baker$22,630,205
- Barry Ryan Lutz$10,006,881
- Allan S Hoffman$2,746,454
- Patricia Pavlinac$6,692,400
- Gregory D Horwitz$10,972,721
Others in their field
Top investigators on “Point Of Care”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Judith S Hochman · New York University School Of Medicine$101,773,796
- Michael S. Saag · University Of Alabama At Birmingham$85,103,222
- Constance Ann Benson · University Of California, San Diego$66,071,396
- Mark Marino · Venturewell$61,796,923
Research focus
Point Of CareSamplingPaperDetectionLateralDiagnosticBaseReagentDiagnosisLaboratoriesLiquid SubstanceMicrofluidicsDevicesDesignValidationBloodPrototypeDiagnosis Design /EvaluationOperationSwabImmunologic Assay /TestImmunoassayCostInstrument
Grant awards (23)
HIVAcute: rapid sample-to-result self-testing for HIV RNA$720,746
R33 · FY2023 · AI · contact PI
HIVAcute: rapid sample-to-result self-testing for HIV RNA$738,364
R33 · FY2022 · AI · contact PI
HIVAcute: rapid sample-to-result self-testing for HIV RNA$432,220
R61 · FY2021 · AI · contact PI
HIVAcute: rapid sample-to-result self-testing for HIV RNA$436,669
R61 · FY2020 · AI · contact PI
HIVAcute: rapid sample-to-result self-testing for HIV RNA$449,887
R61 · FY2019 · AI · contact PI
A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes$188,696
R21 · FY2017 · AI
A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes$221,788
R21 · FY2016 · AI
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension$804,586
R01 · FY2015 · AI · contact PI
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension$898,194
R01 · FY2014 · AI · contact PI
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension$1,074,296
R01 · FY2013 · AI · contact PI
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension$1,177,234
R01 · FY2012 · AI · contact PI
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension$1,262,608
R01 · FY2011 · AI · contact PI
A sensitive multiplexed diagnostic platform using disposable 2D paper networks$494,775
RC1 · FY2010 · EB · contact PI
A sensitive multiplexed diagnostic platform using disposable 2D paper networks$495,659
RC1 · FY2009 · EB · contact PI
Rapid parallel salivary immunoassays on a disposable$846,614
U01 · FY2005 · DE
Rapid parallel salivary immunoassays on a disposable$924,078
U01 · FY2004 · DE
A Microfluidic Diffusion Immunoassay$258,035
R01 · FY2004 · EB
Rapid parallel salivary immunoassays on a disposable$1,026,573
U01 · FY2003 · DE
A Microfluidic Diffusion Immunoassay$255,147
R01 · FY2003 · EB
Rapid parallel salivary immunoassays on a disposable$30,320
U01 · FY2003 · DE
Rapid parallel salivary immunoassays on a disposable$1,000,000
U01 · FY2002 · DE
A Microfluidic Diffusion Immunoassay$258,492
R01 · FY2002 · RR
A Microfluidic Diffusion Immunoassay$290,471
R01 · FY2001 · RR